Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1995
|
| gptkbp:ATCCode |
gptkb:N07XX02
|
| gptkbp:CASNumber |
gptkb:1744-22-5
|
| gptkbp:chemicalFormula |
gptkb:C8H5F3N2OS
|
| gptkbp:eliminationHalfLife |
12 hours
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
gptkb:riluzole
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rilutek
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:mechanismOfAction |
glutamate release inhibitor
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness liver function abnormality |
| gptkbp:synonym |
gptkb:riluzole
|
| gptkbp:usedFor |
amyotrophic lateral sclerosis
|
| gptkbp:bfsParent |
gptkb:riluzole
|
| gptkbp:bfsLayer |
5
|